Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target

1 May 2021

Abstract excerpt

The novel coronavirus disease 2019 (COVID-19) pandemic is severely challenging the healthcare systems and economies of the world, which urgently demand vaccine and therapy development to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, advancing our understanding of the comprehensive entry mechanisms of SARS-CoV-2, especially the host factors that facilitate viral infection, is crucial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Apelin-related biomedical research
Share to Atherosclerosis and Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33986591
DOI: 10.2147/btt.s307352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic TargetPMID 33986591Read ↗

Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infectionSemantic proximity Read ↗

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.Semantic proximity Read ↗

Targeting neuropilins as a viable SARS‐CoV‐2 treatmentSemantic proximity Read ↗

Neuropilin-1 is a host factor for SARS-CoV-2 infectionSemantic proximity Read ↗

Enhancing host cell infection by SARS-CoV-2Semantic proximity Read ↗

Neuropilin-1 Mediates SARS-CoV-2 Infection in Bone Marrow-derived MacrophagesSemantic proximity Read ↗

Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19Semantic proximity Read ↗

NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cellsSemantic proximity Read ↗

ACE2-Independent Alternative Receptors for SARS-CoV-2Semantic proximity Read ↗

Targeting SARS-CoV-2 and host cell receptor interactions.Semantic proximity Read ↗

Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)Semantic proximity Read ↗

Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.